上海交通大学学报(医学版)
 
     首页 |  期刊介绍 |  广告合作 |  联系我们 |  编委会 |  投稿指南 |  期刊订阅 |  留言板 |  English
上海交通大学学报(医学版)  2017, Vol. 37 Issue (8): 1100-    DOI: 10.3969/j.issn.1674-8115.2017.08.010
论著(临床研究) 最新目录| 下期目录| 过刊浏览| 高级检索 |
A phase IV study of homoharringtonine, cytarabine, aclacinomycin and G-CSF (HCAG) regimen compared with traditional IA regimen in the treatment of newly diagnosed elderly acute myeloid leukemia patients#br#
#br# LIU Zhao*, ZHANG Yun-xiang*, WANG Li-ning*, XIA Zheng, MAO Yuan-fei, ZHAO Hui-jin, YOU Jian-hua,  YU Yang, ZHAO Yu-bing, REN Yu-hong, LI Ya, WANG Yan, CHEN Qiu-sheng, LI Jun-min#, CHEN Yu#
Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
A phase IV study of homoharringtonine, cytarabine, aclacinomycin and G-CSF (HCAG) regimen compared with traditional IA regimen in the treatment of newly diagnosed elderly acute myeloid leukemia patients
LIU Zhao*, ZHANG Yun-xiang*, WANG Li-ning*, XIA Zheng, MAO Yuan-fei, ZHAO Hui-jin, YOU Jian-hua,  YU Yang, ZHAO Yu-bing, REN Yu-hong, LI Ya, WANG Yan, CHEN Qiu-sheng, LI Jun-min#, CHEN Yu#
Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

版权所有 © 2009 《上海交通大学学报(医学版)》编辑部
地址:上海市重庆南路280号  邮政编码:200025    电话:021-63846590     Email:xuebao@shsmu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发  技术支持:support@magtech.com.cn